Fennec Pharmaceuticals Inc. Common Stock

FENCNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
10.15 USD
↗ 0.07 (0.69%)AT CLOSE (03:59 PM EDT)
10.13
↘ 0.02 (0.20%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
10.13
↘ 0.02 (0.20%)
🔴Market: CLOSED

Fennec Pharmaceuticals Inc. Common Stock (FENC) is currently trading at $10.14. The technical outlook is "Neutral" and the fundamental picture shows "Buy". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place FENC at a fair price relative to peers.

Technical & fundamental data as of Oct 26, 2026.

Open?$10.08
High?$10.27
Low?$9.98
Prev. Close?$10.08
Volume?115.9K
Avg. Volume?128.3K
VWAP?$10.13
Rel. Volume?0.90x
Bid / Ask
Bid?$10.00 × 100
Ask?$11.48 × 100
Spread?$1.48
Midpoint?$10.74
Valuation & Ratios
Market Cap?355.9M
Shares Out?35.1M
Float?22.1M
Float %?63.1%
P/E Ratio?N/A
P/B Ratio?8.39
EPS?-$0.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Themes
Biotech - Drug Development›Rare Disease Therapeutics
Employees
35
Market Cap
353.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.fennecpharma.com
Listed
2002-01-28
Address
PO BOX 13628
RESEARCH TRIANGLE PARK, NC 27709
Phone: (919) 636-4530
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
90
Momentum?
90
Short Sent.?
63
Piotroski F-Score?6/9Mixed
Altman Z-Score?3.90Safe
Confidence?71%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?2.20%Low
Short Interest?487.5K
Days to Cover?3.8
Free Float22.1M
Avg Daily Volume129.1K
Settlement Date2026-10-15
Financial Health
Current Ratio?5.85Strong
Quick Ratio?5.66Strong
Cash Ratio?3.33Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
22
8.39HIGH▾
P/S?
Peers
100
S&P
22
6.01FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-279.7CHEAP▾
EV/Sales?
Peers
100
S&P
33
5.31FAIR▾
Returns & Efficiency
ROE?
S&P
10
-7.7%WEAK▾
ROA?
S&P
3
-4.3%WEAK▾
Cash Flow & Enterprise
FCF?$-2040000
Enterprise Value?$314.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist